var eventsData = [{"Ticker":"XRAY","EffectiveDate":"2016-12-28","Type":"Dividend","Title":"The Firm pays dividend $0.078","DailyReturn":-0.014273,"FiveDayReturnAfter":0.00183,"FiveDayReturnBefore":-0.010274},{"Ticker":"XRAY","EffectiveDate":"2016-12-05","Type":"RatingUpgrade","Title":"Barrington Research upgrades XRAY to Outperform from Market Perform.","DailyReturn":0.006326,"FiveDayReturnAfter":0.036406,"FiveDayReturnBefore":-0.065296},{"Ticker":"XRAY","EffectiveDate":"2016-11-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.017632,"FiveDayReturnAfter":0.025367,"FiveDayReturnBefore":0.064506},{"Ticker":"XRAY","EffectiveDate":"2016-11-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.017632,"FiveDayReturnAfter":0.025367,"FiveDayReturnBefore":0.064506},{"Ticker":"XRAY","EffectiveDate":"2016-11-04","Type":"EarningsBeatRevenueMiss","Title":"Before market open, XRAY reports 2016 Q3's earning $0.66 per share and revenue $954.2MM. This beats analyst's estimated EPS $0.63, misses estimated revenue $968.1MM.","DailyReturn":0.017632,"FiveDayReturnAfter":0.025367,"FiveDayReturnBefore":0.064506},{"Ticker":"XRAY","EffectiveDate":"2016-11-01","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades XRAY to Overweight from Equal-Weight.","DailyReturn":0.014417,"FiveDayReturnAfter":0.059837,"FiveDayReturnBefore":-0.007096},{"Ticker":"XRAY","EffectiveDate":"2016-10-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.000358,"FiveDayReturnAfter":0.067333,"FiveDayReturnBefore":-0.061793},{"Ticker":"XRAY","EffectiveDate":"2016-10-27","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":-0.000358,"FiveDayReturnAfter":0.067333,"FiveDayReturnBefore":-0.061793},{"Ticker":"XRAY","EffectiveDate":"2016-10-27","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.000358,"FiveDayReturnAfter":0.067333,"FiveDayReturnBefore":-0.061793},{"Ticker":"XRAY","EffectiveDate":"2016-09-28","Type":"Dividend","Title":"The Firm pays dividend $0.078","DailyReturn":0.002825,"FiveDayReturnAfter":-0.009664,"FiveDayReturnBefore":-0.000334},{"Ticker":"XRAY","EffectiveDate":"2016-09-22","Type":"RatingNeutral","Title":"JP Morgan initiates coverage on XRAY to Neutral.","DailyReturn":0.002004,"FiveDayReturnAfter":-0.002871,"FiveDayReturnBefore":0.011083},{"Ticker":"XRAY","EffectiveDate":"2016-08-08","Type":"RatingNeutral","Title":"Barrington Research downgrades XRAY to Market Perform from Outperform.","DailyReturn":-0.017583,"FiveDayReturnAfter":-0.015769,"FiveDayReturnBefore":-0.032534},{"Ticker":"XRAY","EffectiveDate":"2016-08-05","Type":"EarningsBeatRevenueMiss","Title":"Before market open, XRAY reports 2016 Q2's earning $0.76 per share and revenue $1022MM. This beats analyst's estimated EPS $0.7, misses estimated revenue $1030MM.","DailyReturn":-0.026692,"FiveDayReturnAfter":-0.035965,"FiveDayReturnBefore":0.009308},{"Ticker":"XRAY","EffectiveDate":"2016-08-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.026692,"FiveDayReturnAfter":-0.035965,"FiveDayReturnBefore":0.009308},{"Ticker":"XRAY","EffectiveDate":"2016-08-05","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.026692,"FiveDayReturnAfter":-0.035965,"FiveDayReturnBefore":0.009308},{"Ticker":"XRAY","EffectiveDate":"2016-06-27","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.031648,"FiveDayReturnAfter":0.016662,"FiveDayReturnBefore":-0.029453},{"Ticker":"XRAY","EffectiveDate":"2016-06-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.031648,"FiveDayReturnAfter":0.016662,"FiveDayReturnBefore":-0.029453},{"Ticker":"XRAY","EffectiveDate":"2016-06-22","Type":"Dividend","Title":"The Firm pays dividend $0.078","DailyReturn":0.002337,"FiveDayReturnAfter":-0.044764,"FiveDayReturnBefore":-0.013786},{"Ticker":"XRAY","EffectiveDate":"2016-06-13","Type":"RatingNeutral","Title":"PiperJaffray initiates coverage on XRAY to Overweight.","DailyReturn":0.017607,"FiveDayReturnAfter":-0.006308,"FiveDayReturnBefore":0.015206},{"Ticker":"XRAY","EffectiveDate":"2016-05-25","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.000648,"FiveDayReturnAfter":0.012079,"FiveDayReturnBefore":0.016825},{"Ticker":"XRAY","EffectiveDate":"2016-05-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.000648,"FiveDayReturnAfter":0.012079,"FiveDayReturnBefore":0.016825},{"Ticker":"XRAY","EffectiveDate":"2016-05-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.02083,"FiveDayReturnAfter":0.023042,"FiveDayReturnBefore":0.002649},{"Ticker":"XRAY","EffectiveDate":"2016-05-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.02083,"FiveDayReturnAfter":0.023042,"FiveDayReturnBefore":0.002649},{"Ticker":"XRAY","EffectiveDate":"2016-05-06","Type":"EarningsRevenueBeat","Title":"Before market open, XRAY reports 2016 Q1's earning $0.69 per share and revenue $772.6MM. This beats analyst's estimated EPS $0.63, beats estimated revenue $734.75MM.","DailyReturn":0.02083,"FiveDayReturnAfter":0.023042,"FiveDayReturnBefore":0.002649},{"Ticker":"XRAY","EffectiveDate":"2016-03-24","Type":"RatingNeutral","Title":"Morgan Stanley downgrades XRAY to Equal-Weight from Overweight. Target Price is $65.","DailyReturn":-0.015359,"FiveDayReturnAfter":0.017679,"FiveDayReturnBefore":-0.010846},{"Ticker":"XRAY","EffectiveDate":"2016-03-22","Type":"Dividend","Title":"The Firm pays dividend $0.078","DailyReturn":0.016488,"FiveDayReturnAfter":0.033768,"FiveDayReturnBefore":-0.023228},{"Ticker":"XRAY","EffectiveDate":"2016-03-15","Type":"RatingNeutral","Title":"Credit Suisse initiates coverage on XRAY to Outperform. Target Price is $70.","DailyReturn":-0.008305,"FiveDayReturnAfter":-0.023228,"FiveDayReturnBefore":0.006698},{"Ticker":"XRAY","EffectiveDate":"2016-03-14","Type":"RatingNeutral","Title":"William Blair downgrades XRAY to Market Perform from Outperform.","DailyReturn":-0.032761,"FiveDayReturnAfter":-0.044609,"FiveDayReturnBefore":0.053874},{"Ticker":"XRAY","EffectiveDate":"2016-03-03","Type":"RatingUpgrade","Title":"Jefferies upgrades XRAY to Buy from Neutral. Target Price is $70; previously $60.","DailyReturn":0.006977,"FiveDayReturnAfter":0.031235,"FiveDayReturnBefore":0.039301},{"Ticker":"XRAY","EffectiveDate":"2016-02-29","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":0.00478,"FiveDayReturnAfter":-0.00844,"FiveDayReturnBefore":0.073513},{"Ticker":"XRAY","EffectiveDate":"2016-02-29","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.00478,"FiveDayReturnAfter":-0.00844,"FiveDayReturnBefore":0.073513},{"Ticker":"XRAY","EffectiveDate":"2016-02-29","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":0.00478,"FiveDayReturnAfter":-0.00844,"FiveDayReturnBefore":0.073513},{"Ticker":"XRAY","EffectiveDate":"2016-02-29","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.00478,"FiveDayReturnAfter":-0.00844,"FiveDayReturnBefore":0.073513},{"Ticker":"XRAY","EffectiveDate":"2016-02-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.00478,"FiveDayReturnAfter":-0.00844,"FiveDayReturnBefore":0.073513},{"Ticker":"XRAY","EffectiveDate":"2016-02-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.00478,"FiveDayReturnAfter":-0.00844,"FiveDayReturnBefore":0.073513},{"Ticker":"XRAY","EffectiveDate":"2016-02-25","Type":"RatingUpgrade","Title":"UBS upgrades XRAY to Neutral from Sell. Target Price is $60.","DailyReturn":0.049413,"FiveDayReturnAfter":0.039301,"FiveDayReturnBefore":0.03463},{"Ticker":"XRAY","EffectiveDate":"2016-02-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.031499,"FiveDayReturnAfter":-0.002481,"FiveDayReturnBefore":-0.048529},{"Ticker":"XRAY","EffectiveDate":"2016-02-12","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.031499,"FiveDayReturnAfter":-0.002481,"FiveDayReturnBefore":-0.048529},{"Ticker":"XRAY","EffectiveDate":"2016-01-11","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.019477,"FiveDayReturnAfter":-0.008812,"FiveDayReturnBefore":-0.065537},{"Ticker":"XRAY","EffectiveDate":"2016-01-11","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.019477,"FiveDayReturnAfter":-0.008812,"FiveDayReturnBefore":-0.065537},{"Ticker":"XRAY","EffectiveDate":"2016-01-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.019477,"FiveDayReturnAfter":-0.008812,"FiveDayReturnBefore":-0.065537},{"Ticker":"XRAY","EffectiveDate":"2015-12-22","Type":"Dividend","Title":"The Firm pays dividend $0.073","DailyReturn":0.010054,"FiveDayReturnAfter":0.03172,"FiveDayReturnBefore":0.006181},{"Ticker":"XRAY","EffectiveDate":"2015-12-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.017743,"FiveDayReturnAfter":-0.010071,"FiveDayReturnBefore":-0.028183},{"Ticker":"XRAY","EffectiveDate":"2015-12-11","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":-0.017743,"FiveDayReturnAfter":-0.010071,"FiveDayReturnBefore":-0.028183},{"Ticker":"XRAY","EffectiveDate":"2015-12-11","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.017743,"FiveDayReturnAfter":-0.010071,"FiveDayReturnBefore":-0.028183},{"Ticker":"XRAY","EffectiveDate":"2015-12-11","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.017743,"FiveDayReturnAfter":-0.010071,"FiveDayReturnBefore":-0.028183},{"Ticker":"XRAY","EffectiveDate":"2015-12-10","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.000328,"FiveDayReturnAfter":-0.007251,"FiveDayReturnBefore":-0.025136},{"Ticker":"XRAY","EffectiveDate":"2015-12-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.000328,"FiveDayReturnAfter":-0.007251,"FiveDayReturnBefore":-0.025136},{"Ticker":"XRAY","EffectiveDate":"2015-11-20","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.002783,"FiveDayReturnAfter":0.000328,"FiveDayReturnBefore":0.023854},{"Ticker":"XRAY","EffectiveDate":"2015-11-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.002783,"FiveDayReturnAfter":0.000328,"FiveDayReturnBefore":0.023854},{"Ticker":"XRAY","EffectiveDate":"2015-11-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.004694,"FiveDayReturnAfter":0.023854,"FiveDayReturnBefore":-0.031355},{"Ticker":"XRAY","EffectiveDate":"2015-11-13","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.004694,"FiveDayReturnAfter":0.023854,"FiveDayReturnBefore":-0.031355},{"Ticker":"XRAY","EffectiveDate":"2015-10-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.021934,"FiveDayReturnAfter":0.045516,"FiveDayReturnBefore":0.02598},{"Ticker":"XRAY","EffectiveDate":"2015-10-29","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.021934,"FiveDayReturnAfter":0.045516,"FiveDayReturnBefore":0.02598},{"Ticker":"XRAY","EffectiveDate":"2015-10-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.004576,"FiveDayReturnAfter":0.051048,"FiveDayReturnBefore":0.035188},{"Ticker":"XRAY","EffectiveDate":"2015-10-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.004576,"FiveDayReturnAfter":0.051048,"FiveDayReturnBefore":0.035188},{"Ticker":"XRAY","EffectiveDate":"2015-10-28","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.004576,"FiveDayReturnAfter":0.051048,"FiveDayReturnBefore":0.035188},{"Ticker":"XRAY","EffectiveDate":"2015-10-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.004576,"FiveDayReturnAfter":0.051048,"FiveDayReturnBefore":0.035188},{"Ticker":"XRAY","EffectiveDate":"2015-09-23","Type":"Dividend","Title":"The Firm pays dividend $0.073","DailyReturn":0.010165,"FiveDayReturnAfter":-0.037243,"FiveDayReturnBefore":-0.034441},{"Ticker":"XRAY","EffectiveDate":"2015-09-21","Type":"RatingUpgrade","Title":"William Blair upgrades XRAY to Outperform.","DailyReturn":0.004729,"FiveDayReturnAfter":-0.016551,"FiveDayReturnBefore":0.00512},{"Ticker":"XRAY","EffectiveDate":"2015-09-21","Type":"RatingUpgrade","Title":"Northcoast Research upgrades XRAY to Outperform from Market Perform.","DailyReturn":0.004729,"FiveDayReturnAfter":-0.016551,"FiveDayReturnBefore":0.00512},{"Ticker":"XRAY","EffectiveDate":"2015-09-16","Type":"RatingUpgrade","Title":"Baird upgrades XRAY to Outperform. Target Price is $61; previously $58.","DailyReturn":-0.023551,"FiveDayReturnAfter":-0.034441,"FiveDayReturnBefore":0.036346},{"Ticker":"XRAY","EffectiveDate":"2015-09-16","Type":"RatingUpgrade","Title":"Barrington Research upgrades XRAY to Outperform from Market Perform. Target Price is $60.","DailyReturn":-0.023551,"FiveDayReturnAfter":-0.034441,"FiveDayReturnBefore":0.036346},{"Ticker":"XRAY","EffectiveDate":"2015-09-16","Type":"RatingNeutral","Title":"Bank of America maintains XRAY to Buy. Target Price is $65; previously $60.","DailyReturn":-0.023551,"FiveDayReturnAfter":-0.034441,"FiveDayReturnBefore":0.036346},{"Ticker":"XRAY","EffectiveDate":"2015-09-15","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.013614,"FiveDayReturnAfter":-0.009558,"FiveDayReturnBefore":0.046182},{"Ticker":"XRAY","EffectiveDate":"2015-09-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.013614,"FiveDayReturnAfter":-0.009558,"FiveDayReturnBefore":0.046182},{"Ticker":"XRAY","EffectiveDate":"2015-09-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.013614,"FiveDayReturnAfter":-0.009558,"FiveDayReturnBefore":0.046182},{"Ticker":"XRAY","EffectiveDate":"2015-09-15","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.013614,"FiveDayReturnAfter":-0.009558,"FiveDayReturnBefore":0.046182},{"Ticker":"XRAY","EffectiveDate":"2015-09-14","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades XRAY to Overweight.","DailyReturn":0.019585,"FiveDayReturnAfter":0.00512,"FiveDayReturnBefore":0.017648},{"Ticker":"XRAY","EffectiveDate":"2015-07-31","Type":"RatingNeutral","Title":"Credit Suisse maintains XRAY to Outperform. Target Price is $63; previously $61.","DailyReturn":0.015162,"FiveDayReturnAfter":-0.005906,"FiveDayReturnBefore":0.061428},{"Ticker":"XRAY","EffectiveDate":"2015-07-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.043171,"FiveDayReturnAfter":0.049019,"FiveDayReturnBefore":0.022012},{"Ticker":"XRAY","EffectiveDate":"2015-07-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.043171,"FiveDayReturnAfter":0.049019,"FiveDayReturnBefore":0.022012},{"Ticker":"XRAY","EffectiveDate":"2015-06-24","Type":"Dividend","Title":"The Firm pays dividend $0.073","DailyReturn":-0.015407,"FiveDayReturnAfter":-0.02825,"FiveDayReturnBefore":0.021895},{"Ticker":"XRAY","EffectiveDate":"2015-05-22","Type":"Item_2.05","Title":"Costs Associated with Exit or Disposal Activities\r\n","DailyReturn":-0.009738,"FiveDayReturnAfter":-0.006321,"FiveDayReturnBefore":0.014425},{"Ticker":"XRAY","EffectiveDate":"2015-05-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.009738,"FiveDayReturnAfter":-0.006321,"FiveDayReturnBefore":0.014425},{"Ticker":"XRAY","EffectiveDate":"2015-05-20","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.00057,"FiveDayReturnAfter":-0.014735,"FiveDayReturnBefore":0.0417},{"Ticker":"XRAY","EffectiveDate":"2015-05-20","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.00057,"FiveDayReturnAfter":-0.014735,"FiveDayReturnBefore":0.0417},{"Ticker":"XRAY","EffectiveDate":"2015-05-20","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.00057,"FiveDayReturnAfter":-0.014735,"FiveDayReturnBefore":0.0417},{"Ticker":"XRAY","EffectiveDate":"2015-05-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.00057,"FiveDayReturnAfter":-0.014735,"FiveDayReturnBefore":0.0417},{"Ticker":"XRAY","EffectiveDate":"2015-05-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.023787,"FiveDayReturnAfter":-0.031964,"FiveDayReturnBefore":0.012547},{"Ticker":"XRAY","EffectiveDate":"2015-05-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.023787,"FiveDayReturnAfter":-0.031964,"FiveDayReturnBefore":0.012547},{"Ticker":"XRAY","EffectiveDate":"2015-03-25","Type":"Dividend","Title":"The Firm pays dividend $0.072","DailyReturn":-0.019687,"FiveDayReturnAfter":-0.015945,"FiveDayReturnBefore":0.012633},{"Ticker":"XRAY","EffectiveDate":"2015-02-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.017284,"FiveDayReturnAfter":-0.00152,"FiveDayReturnBefore":0.051444},{"Ticker":"XRAY","EffectiveDate":"2015-02-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.017284,"FiveDayReturnAfter":-0.00152,"FiveDayReturnBefore":0.051444},{"Ticker":"XRAY","EffectiveDate":"2015-01-22","Type":"RatingNeutral","Title":"Barrington Research assumes XRAY to Market Perform.","DailyReturn":0.014759,"FiveDayReturnAfter":-0.002996,"FiveDayReturnBefore":-0.038345},{"Ticker":"XRAY","EffectiveDate":"2015-01-02","Type":"RatingNeutral","Title":"Baird downgrades XRAY to Neutral from Outperform. Target Price is $55.","DailyReturn":-0.025155,"FiveDayReturnAfter":0.005056,"FiveDayReturnBefore":-0.01361},{"Ticker":"XRAY","EffectiveDate":"2014-12-23","Type":"Dividend","Title":"The Firm pays dividend $0.066","DailyReturn":-0.000444,"FiveDayReturnAfter":-0.012741,"FiveDayReturnBefore":0.012652},{"Ticker":"XRAY","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Credit Suisse maintains XRAY to Outperform. Target Price is $55; previously $54.","DailyReturn":0.015612,"FiveDayReturnAfter":0.045578,"FiveDayReturnBefore":0.08018},{"Ticker":"XRAY","EffectiveDate":"2014-10-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.03657,"FiveDayReturnAfter":0.064892,"FiveDayReturnBefore":0.035079},{"Ticker":"XRAY","EffectiveDate":"2014-10-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.03657,"FiveDayReturnAfter":0.064892,"FiveDayReturnBefore":0.035079},{"Ticker":"XRAY","EffectiveDate":"2014-10-20","Type":"RatingNeutral","Title":"Goldman Sachs downgrades XRAY to Neutral from Buy.","DailyReturn":-0.011921,"FiveDayReturnAfter":0.018374,"FiveDayReturnBefore":0.008202},{"Ticker":"XRAY","EffectiveDate":"2014-09-24","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":0.011069,"FiveDayReturnAfter":-0.002496,"FiveDayReturnBefore":-0.017108},{"Ticker":"XRAY","EffectiveDate":"2014-09-24","Type":"Dividend","Title":"The Firm pays dividend $0.066","DailyReturn":0.011069,"FiveDayReturnAfter":-0.002496,"FiveDayReturnBefore":-0.017108},{"Ticker":"XRAY","EffectiveDate":"2014-09-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.011069,"FiveDayReturnAfter":-0.002496,"FiveDayReturnBefore":-0.017108},{"Ticker":"XRAY","EffectiveDate":"2014-07-31","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.021501,"FiveDayReturnAfter":-0.012943,"FiveDayReturnBefore":0.013369},{"Ticker":"XRAY","EffectiveDate":"2014-07-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.021501,"FiveDayReturnAfter":-0.012943,"FiveDayReturnBefore":0.013369},{"Ticker":"XRAY","EffectiveDate":"2014-06-25","Type":"Dividend","Title":"The Firm pays dividend $0.066","DailyReturn":0.011075,"FiveDayReturnAfter":0.000337,"FiveDayReturnBefore":-0.00273},{"Ticker":"XRAY","EffectiveDate":"2014-05-21","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.008844,"FiveDayReturnAfter":0.018804,"FiveDayReturnBefore":-0.004733},{"Ticker":"XRAY","EffectiveDate":"2014-05-21","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.008844,"FiveDayReturnAfter":0.018804,"FiveDayReturnBefore":-0.004733},{"Ticker":"XRAY","EffectiveDate":"2014-05-16","Type":"RatingUpgrade","Title":"Barrington Research upgrades XRAY to Outperform from Market Perform.","DailyReturn":0.009356,"FiveDayReturnAfter":0.020035,"FiveDayReturnBefore":0.006329},{"Ticker":"XRAY","EffectiveDate":"2014-05-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.001539,"FiveDayReturnAfter":0.021109,"FiveDayReturnBefore":0.019766},{"Ticker":"XRAY","EffectiveDate":"2014-05-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.001539,"FiveDayReturnAfter":0.021109,"FiveDayReturnBefore":0.019766},{"Ticker":"XRAY","EffectiveDate":"2014-03-26","Type":"Dividend","Title":"The Firm pays dividend $0.066","DailyReturn":-0.000308,"FiveDayReturnAfter":0.032787,"FiveDayReturnBefore":-0.007219},{"Ticker":"XRAY","EffectiveDate":"2014-02-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.011895,"FiveDayReturnAfter":-0.024743,"FiveDayReturnBefore":0.013718},{"Ticker":"XRAY","EffectiveDate":"2014-02-18","Type":"RevenueBeat","Title":"After market close, XRAY reports 2013 Q4's earning $0.61 per share and revenue $753.7MM. This meets analyst's estimated EPS $0.61, misses estimated revenue $767.89MM.","DailyReturn":-0.011895,"FiveDayReturnAfter":-0.024743,"FiveDayReturnBefore":0.013718},{"Ticker":"XRAY","EffectiveDate":"2014-02-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.011895,"FiveDayReturnAfter":-0.024743,"FiveDayReturnBefore":0.013718},{"Ticker":"XRAY","EffectiveDate":"2013-12-24","Type":"Dividend","Title":"The Firm pays dividend $0.063","DailyReturn":-0.001168,"FiveDayReturnAfter":-0.006518,"FiveDayReturnBefore":0.024657},{"Ticker":"XRAY","EffectiveDate":"2013-12-11","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades XRAY to Buy from Neutral. Target Price is $56; previously $45.","DailyReturn":0.008737,"FiveDayReturnAfter":-0.012772,"FiveDayReturnBefore":0.017841},{"Ticker":"XRAY","EffectiveDate":"2013-12-11","Type":"RatingUpgrade","Title":"Credit Suisse upgrades XRAY to Outperform from Neutral.","DailyReturn":0.008737,"FiveDayReturnAfter":-0.012772,"FiveDayReturnBefore":0.017841},{"Ticker":"XRAY","EffectiveDate":"2013-10-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.016229,"FiveDayReturnAfter":0.053458,"FiveDayReturnBefore":-0.016537},{"Ticker":"XRAY","EffectiveDate":"2013-10-29","Type":"EarningsBeatRevenueMiss","Title":"Before market open, XRAY reports 2013 Q3's earning $0.57 per share and revenue $704MM. This beats analyst's estimated EPS $0.56, misses estimated revenue $716.13MM.","DailyReturn":0.016229,"FiveDayReturnAfter":0.053458,"FiveDayReturnBefore":-0.016537},{"Ticker":"XRAY","EffectiveDate":"2013-10-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.016229,"FiveDayReturnAfter":0.053458,"FiveDayReturnBefore":-0.016537},{"Ticker":"XRAY","EffectiveDate":"2013-10-04","Type":"RatingUpgrade","Title":"Bank of America upgrades XRAY to Buy from Underperform. Target Price is $48; previously $35.","DailyReturn":0.029385,"FiveDayReturnAfter":0.019931,"FiveDayReturnBefore":-0.006687},{"Ticker":"XRAY","EffectiveDate":"2013-09-25","Type":"Dividend","Title":"The Firm pays dividend $0.063","DailyReturn":-0.009736,"FiveDayReturnAfter":-0.005419,"FiveDayReturnBefore":-0.013344},{"Ticker":"XRAY","EffectiveDate":"2013-08-27","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":-0.006413,"FiveDayReturnAfter":-0.002378,"FiveDayReturnBefore":0.007391},{"Ticker":"XRAY","EffectiveDate":"2013-08-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.006413,"FiveDayReturnAfter":-0.002378,"FiveDayReturnBefore":0.007391},{"Ticker":"XRAY","EffectiveDate":"2013-08-06","Type":"RatingNeutral","Title":"Northcoast Research downgrades XRAY to Neutral from Buy.","DailyReturn":-0.00281,"FiveDayReturnAfter":0.000235,"FiveDayReturnBefore":0.014152},{"Ticker":"XRAY","EffectiveDate":"2013-08-01","Type":"EarningsBeatRevenueMiss","Title":"Before market open, XRAY reports 2013 Q2's earning $0.66 per share and revenue $761.01MM. This beats analyst's estimated EPS $0.65, misses estimated revenue $782.73MM.","DailyReturn":0.000466,"FiveDayReturnAfter":-0.011256,"FiveDayReturnBefore":0.013146},{"Ticker":"XRAY","EffectiveDate":"2013-08-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.000466,"FiveDayReturnAfter":-0.011256,"FiveDayReturnBefore":0.013146},{"Ticker":"XRAY","EffectiveDate":"2013-08-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.000466,"FiveDayReturnAfter":-0.011256,"FiveDayReturnBefore":0.013146},{"Ticker":"XRAY","EffectiveDate":"2013-06-26","Type":"Dividend","Title":"The Firm pays dividend $0.063","DailyReturn":0.007293,"FiveDayReturnAfter":0.022713,"FiveDayReturnBefore":-0.037555},{"Ticker":"XRAY","EffectiveDate":"2013-05-23","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.000964,"FiveDayReturnAfter":0.012699,"FiveDayReturnBefore":-0.025239},{"Ticker":"XRAY","EffectiveDate":"2013-05-23","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.000964,"FiveDayReturnAfter":0.012699,"FiveDayReturnBefore":-0.025239},{"Ticker":"XRAY","EffectiveDate":"2013-05-20","Type":"RatingNeutral","Title":"Barrington Research downgrades XRAY to Market Perform from Outperform.","DailyReturn":-0.002365,"FiveDayReturnAfter":-0.027091,"FiveDayReturnBefore":-0.008477},{"Ticker":"XRAY","EffectiveDate":"2013-05-09","Type":"EarningsRevenueMiss","Title":"Before market open, XRAY reports 2013 Q1's earning $0.52 per share and revenue $732.1MM. This misses analyst's estimated EPS $0.56, misses estimated revenue $732.87MM.","DailyReturn":-0.039593,"FiveDayReturnAfter":-0.038514,"FiveDayReturnBefore":0.055349},{"Ticker":"XRAY","EffectiveDate":"2013-05-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.018668,"FiveDayReturnAfter":-0.01369,"FiveDayReturnBefore":0.024259},{"Ticker":"XRAY","EffectiveDate":"2013-05-08","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.018668,"FiveDayReturnAfter":-0.01369,"FiveDayReturnBefore":0.024259},{"Ticker":"XRAY","EffectiveDate":"2013-04-15","Type":"RatingUpgrade","Title":"Citigroup upgrades XRAY to Buy from Neutral. Target Price is $49; previously $39.65.","DailyReturn":-0.020219,"FiveDayReturnAfter":-0.011484,"FiveDayReturnBefore":0.031656},{"Ticker":"XRAY","EffectiveDate":"2013-04-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.009821,"FiveDayReturnAfter":0.031656,"FiveDayReturnBefore":-0.041126},{"Ticker":"XRAY","EffectiveDate":"2013-04-08","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.009821,"FiveDayReturnAfter":0.031656,"FiveDayReturnBefore":-0.041126},{"Ticker":"XRAY","EffectiveDate":"2013-03-26","Type":"Dividend","Title":"The Firm pays dividend $0.063","DailyReturn":0.007042,"FiveDayReturnAfter":0.000313,"FiveDayReturnBefore":0.000001},{"Ticker":"XRAY","EffectiveDate":"2013-02-21","Type":"RatingNeutral","Title":"Wellington Shields downgrades XRAY to Hold from Gradually Accumulate.","DailyReturn":-0.039302,"FiveDayReturnAfter":-0.040337,"FiveDayReturnBefore":0.003028},{"Ticker":"XRAY","EffectiveDate":"2013-02-21","Type":"RatingNeutral","Title":"UBS maintains XRAY to Sell. Target Price is $38; previously $35.","DailyReturn":-0.039302,"FiveDayReturnAfter":-0.040337,"FiveDayReturnBefore":0.003028},{"Ticker":"XRAY","EffectiveDate":"2013-02-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.011267,"FiveDayReturnAfter":-0.06189,"FiveDayReturnBefore":0.015059},{"Ticker":"XRAY","EffectiveDate":"2013-02-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.011267,"FiveDayReturnAfter":-0.06189,"FiveDayReturnBefore":0.015059},{"Ticker":"XRAY","EffectiveDate":"2013-02-20","Type":"EarningsRelease","Title":"Before market open, XRAY reports 2012 Q4's earning $0.56 per share and revenue $753.3MM. This meets analyst's estimated EPS $0.56, beats estimated revenue $742.7MM.","DailyReturn":-0.011267,"FiveDayReturnAfter":-0.06189,"FiveDayReturnBefore":0.015059},{"Ticker":"XRAY","EffectiveDate":"2012-12-26","Type":"Dividend","Title":"The Firm pays dividend $0.055","DailyReturn":-0.012114,"FiveDayReturnAfter":0.012043,"FiveDayReturnBefore":-0.006713},{"Ticker":"XRAY","EffectiveDate":"2012-11-08","Type":"RatingNeutral","Title":"Stifel Nicolaus initiates coverage on XRAY to Hold.","DailyReturn":-0.016309,"FiveDayReturnAfter":-0.017232,"FiveDayReturnBefore":0.047444},{"Ticker":"XRAY","EffectiveDate":"2012-10-25","Type":"EarningsRelease","Title":"Before market open, XRAY reports 2012 Q3's earning $0.37 per share and revenue $695.73MM..","DailyReturn":0.016889,"FiveDayReturnAfter":0.035327,"FiveDayReturnBefore":-0.037952},{"Ticker":"XRAY","EffectiveDate":"2012-10-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.01493,"FiveDayReturnAfter":0.058526,"FiveDayReturnBefore":-0.038774},{"Ticker":"XRAY","EffectiveDate":"2012-10-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.01493,"FiveDayReturnAfter":0.058526,"FiveDayReturnBefore":-0.038774},{"Ticker":"XRAY","EffectiveDate":"2012-10-22","Type":"RatingNeutral","Title":"UBS downgrades XRAY to Sell from Neutral. Target Price is $35; previously $39.","DailyReturn":-0.013276,"FiveDayReturnAfter":0.006751,"FiveDayReturnBefore":-0.002705},{"Ticker":"XRAY","EffectiveDate":"2012-09-26","Type":"Dividend","Title":"The Firm pays dividend $0.055","DailyReturn":-0.002784,"FiveDayReturnAfter":0.009106,"FiveDayReturnBefore":0.012253},{"Ticker":"XRAY","EffectiveDate":"2012-08-01","Type":"RatingNeutral","Title":"Jefferies maintains XRAY to Buy. Target Price is $44; previously $46.","DailyReturn":-0.005779,"FiveDayReturnAfter":0.050701,"FiveDayReturnBefore":0.021697},{"Ticker":"XRAY","EffectiveDate":"2012-07-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.02443,"FiveDayReturnAfter":0.008021,"FiveDayReturnBefore":0.031082},{"Ticker":"XRAY","EffectiveDate":"2012-07-31","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.02443,"FiveDayReturnAfter":0.008021,"FiveDayReturnBefore":0.031082},{"Ticker":"XRAY","EffectiveDate":"2012-07-31","Type":"EarningsRevenueBeat","Title":"Before market open, XRAY reports 2012 Q2's earning $0.62 per share and revenue $763MM. This beats analyst's estimated EPS $0.57, beats estimated revenue $747.92MM.","DailyReturn":-0.02443,"FiveDayReturnAfter":0.008021,"FiveDayReturnBefore":0.031082},{"Ticker":"XRAY","EffectiveDate":"2012-07-03","Type":"RatingNeutral","Title":"UBS initiates coverage on XRAY to Neutral. Target Price is $41.","DailyReturn":-0.005012,"FiveDayReturnAfter":-0.041472,"FiveDayReturnBefore":0.034215},{"Ticker":"XRAY","EffectiveDate":"2012-06-27","Type":"Dividend","Title":"The Firm pays dividend $0.055","DailyReturn":0.011893,"FiveDayReturnAfter":0.030826,"FiveDayReturnBefore":-0.046147},{"Ticker":"XRAY","EffectiveDate":"2012-05-25","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.011545,"FiveDayReturnAfter":-0.049762,"FiveDayReturnBefore":0.005789},{"Ticker":"XRAY","EffectiveDate":"2012-05-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.011545,"FiveDayReturnAfter":-0.049762,"FiveDayReturnBefore":0.005789},{"Ticker":"XRAY","EffectiveDate":"2012-05-02","Type":"RatingNeutral","Title":"Jefferies maintains XRAY to Buy. Target Price is $46; previously $45.","DailyReturn":-0.00666,"FiveDayReturnAfter":-0.025736,"FiveDayReturnBefore":0.013912},{"Ticker":"XRAY","EffectiveDate":"2012-05-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.012664,"FiveDayReturnAfter":-0.048657,"FiveDayReturnBefore":0.044576},{"Ticker":"XRAY","EffectiveDate":"2012-05-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.012664,"FiveDayReturnAfter":-0.048657,"FiveDayReturnBefore":0.044576},{"Ticker":"XRAY","EffectiveDate":"2012-03-28","Type":"Dividend","Title":"The Firm pays dividend $0.055","DailyReturn":-0.000625,"FiveDayReturnAfter":0.005107,"FiveDayReturnBefore":0.023726},{"Ticker":"XRAY","EffectiveDate":"2012-02-16","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.018337,"FiveDayReturnAfter":-0.014831,"FiveDayReturnBefore":0.022726},{"Ticker":"XRAY","EffectiveDate":"2012-02-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.018337,"FiveDayReturnAfter":-0.014831,"FiveDayReturnBefore":0.022726}];